KR20030030867A - 혈행 개선약 - Google Patents

혈행 개선약 Download PDF

Info

Publication number
KR20030030867A
KR20030030867A KR1020020059691A KR20020059691A KR20030030867A KR 20030030867 A KR20030030867 A KR 20030030867A KR 1020020059691 A KR1020020059691 A KR 1020020059691A KR 20020059691 A KR20020059691 A KR 20020059691A KR 20030030867 A KR20030030867 A KR 20030030867A
Authority
KR
South Korea
Prior art keywords
blood circulation
vitamin
tocopherol
circulation improving
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020020059691A
Other languages
English (en)
Korean (ko)
Inventor
오카다미노루
스에히로요시오키
사카이히로타카
이마모리카츠미
Original Assignee
에스에스 세야쿠 가부시키 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에스에스 세야쿠 가부시키 가이샤 filed Critical 에스에스 세야쿠 가부시키 가이샤
Publication of KR20030030867A publication Critical patent/KR20030030867A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020020059691A 2001-10-11 2002-10-01 혈행 개선약 Ceased KR20030030867A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001314228A JP2003119135A (ja) 2001-10-11 2001-10-11 血行改善薬
JPJP-P-2001-00314228 2001-10-11

Publications (1)

Publication Number Publication Date
KR20030030867A true KR20030030867A (ko) 2003-04-18

Family

ID=19132579

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020020059691A Ceased KR20030030867A (ko) 2001-10-11 2002-10-01 혈행 개선약

Country Status (4)

Country Link
JP (1) JP2003119135A (https=)
KR (1) KR20030030867A (https=)
CN (1) CN1230172C (https=)
TW (1) TWI262074B (https=)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277609A (ja) * 1985-06-01 1986-12-08 Mikasa Kagaku Kogyo Kk 入浴剤
JPS62123108A (ja) * 1985-11-21 1987-06-04 Kanebo Ltd 養毛化粧料
JPS62123105A (ja) * 1985-11-21 1987-06-04 Kanebo Ltd 皮膚化粧料
US4983626A (en) * 1984-02-15 1991-01-08 Roshdy Ismail Anti-rheumatic agents and their use
KR930019221A (ko) * 1992-03-02 1993-10-18 이승철 성인병 예방 및 치료용 순환계용계약 조성물
US5811547A (en) * 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983626A (en) * 1984-02-15 1991-01-08 Roshdy Ismail Anti-rheumatic agents and their use
JPS61277609A (ja) * 1985-06-01 1986-12-08 Mikasa Kagaku Kogyo Kk 入浴剤
JPS62123108A (ja) * 1985-11-21 1987-06-04 Kanebo Ltd 養毛化粧料
JPS62123105A (ja) * 1985-11-21 1987-06-04 Kanebo Ltd 皮膚化粧料
KR930019221A (ko) * 1992-03-02 1993-10-18 이승철 성인병 예방 및 치료용 순환계용계약 조성물
US5811547A (en) * 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance

Also Published As

Publication number Publication date
JP2003119135A (ja) 2003-04-23
HK1054696A1 (en) 2003-12-12
CN1411811A (zh) 2003-04-23
TWI262074B (en) 2006-09-21
CN1230172C (zh) 2005-12-07

Similar Documents

Publication Publication Date Title
US5073376A (en) Preparations containing l-carnitine
KR20010030798A (ko) 경구 투여 제제
JPH11514629A (ja) 安定な甲状腺ホルモン含有薬剤
CA2664406A1 (en) Mixture of iron and copper salts masking metallic taste
JPH01294631A (ja) 糖尿性疾患治療予防剤及び飲食、し好物
US10391103B2 (en) Ferroporphyrin solid dispersion and preparation method thereof
DK169605B1 (da) Magnesiumadditiv til nærings-, foder- og lægemidler
JP2008201711A (ja) システイン臭が低減された固形製剤
JP4501024B2 (ja) システイン類の苦味及び臭気が軽減された組成物
TW200812594A (en) Medicine for prevention of and/or recovery from fatigue
US6017946A (en) Serotonin containing formulation for oral administration and method of use
JP5209876B2 (ja) 速崩壊性錠剤及びその製造方法
EP1707192B1 (en) Pharmaceutical composition
JPS5938203B2 (ja) 補酵素ｑを主成分とする脳循環障害治療剤
TWI837375B (zh) 水溶性o-醣苷基類黃酮組成物及其製備方法
KR20030030867A (ko) 혈행 개선약
KR20210110450A (ko) iLet(innovative Low excipient tablet) 기술을 이용한 정제사이즈 축소를 통해 복용편의성이 증가된 종합비타민제 조성물 및 그 제조방법
JP2008201712A (ja) フィルムコーティング製剤
JP2005220025A (ja) 経口摂取組成物
EP0206240A2 (en) Solid pharmaceutical composition for oral use
TWI536992B (zh) And a medicinal composition for oral administration of improved elution and / or absorption
JP2001122788A (ja) 医薬用固形組成物
KR20000046974A (ko) 아세글루타미드 알루미늄의 경구 투여용 제제 조성물ㅇ
KR20220024544A (ko) 메트포르민 및 칼슘 시트레이트를 포함하는 약학적 투여 형태
NZ517472A (en) Lactose free norastemizole formulations with improved stability

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20021001

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20070912

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 20021001

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20080822

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20081030

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20080822

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I